N/A N=40 Single-blind Prevention

Effect-site Concentration of Propofol for I-gel Insertion During Anesthesia Induction With a Single-dose Dexmedetomidine

Igel

Bottom Line

View on ClinicalTrials.gov: NCT02268656 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2022

Primary outcome: Primary: Concentration of Propofol — 5.46; 3.82 ug/ml

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: propofol concentration (Drug)
Age: Adult · 20+ yrs
Sex: All
Sponsor: Gachon University Gil Medical Center
Primary completion: Feb 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Concentration of Propofol	5.46; 3.82	—

Summary

Before anethetic induction, infuse dexmedetomidine 0.5 mcg/kg for 2 minutes and after injection of lidocaine 30 mg, propofol infusion by using target controlled infusion (TCI) pump. Effect site concentraion of propofol start from 5 and changes the concentration as previous response to i-gel insertion as up and down methods

Eligibility Criteria

Inclusion Criteria

ASA PS I-II, 20-60 yrs old

Exclusion Criteria

predicted difficulty airway, recent URI, BMI > 30kg/m2, reactive airway disease

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02268656). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.